Literature DB >> 7050185

Lysozyme in chronic liver disease: a biochemical and histological study.

I H Manifold, F M Bishop, P Cloke, D R Triger, J C Underwood.   

Abstract

Serum lysozyme activities and semiquantitative analysis of tissue lysozyme distribution were studied in patients with primary biliary cirrhosis (PBC), chronic hepatitis (CH), miscellaneous liver diseases, and normal subjects. Serum lysozyme was significantly raised in PBC and CH. Portal venous blood has similar lysozyme activities to peripheral venous blood in a group of various liver diseases. Lysozyme-containing intralobular cells were decreased in all liver diseases studied but portal tract lysozyme was increased only in PBC and CH. Thus the increase in serum lysozyme in PBC and CH appears to originate from the portal inflammatory infiltrate, seen in these diseases.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7050185      PMCID: PMC497795          DOI: 10.1136/jcp.35.8.815

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  20 in total

1.  The measurement of lysozyme activity and the ultra-violet inactivation of lysozyme.

Authors:  D SHUGAR
Journal:  Biochim Biophys Acta       Date:  1952-03

2.  Serum lysozyme in inflammatory bowel and coeliac disease.

Authors:  E Mallas; J M Terry; P Asquith; W T Cooke
Journal:  J Clin Pathol       Date:  1976-07       Impact factor: 3.411

3.  Localization of lysozyme in normal rat tissues by an immunoperoxidase method.

Authors:  M Klockars; E F Osserman
Journal:  J Histochem Cytochem       Date:  1974-03       Impact factor: 2.479

4.  Ultrastructural immunocytochemical localization of lysozyme in the Paneth cells of man.

Authors:  S L Erlandsen; J A Parsons; T D Taylor
Journal:  J Histochem Cytochem       Date:  1974-06       Impact factor: 2.479

5.  Serum lysozyme in pulmonary tuberculosis.

Authors:  P E Perillie; K Khan; S C Finch
Journal:  Am J Med Sci       Date:  1973-04       Impact factor: 2.378

6.  [Immunologic reactions in chronic liver disease].

Authors:  Z A Bondar'; L G Finogenova; R P Zolotnitskaia
Journal:  Ter Arkh       Date:  1971-08       Impact factor: 0.467

7.  Serum muramidase and granulocyte turnover.

Authors:  M E Fink; S C Finch
Journal:  Proc Soc Exp Biol Med       Date:  1968-02

8.  In vitro synthesis of lysozyme by human and mouse tissues and leucocytes.

Authors:  D B McClelland; R van Furth
Journal:  Immunology       Date:  1975-06       Impact factor: 7.397

9.  Jejunal lysozyme activity and the Paneth cell in coeliac disease.

Authors:  M Ward; A Ferguson; M A Eastwood
Journal:  Gut       Date:  1979-01       Impact factor: 23.059

10.  Muramidase (lysozyme) in Crohn's disease and in ulcerative colitis.

Authors:  W Pruzanski; N Marcon; C Ottaway; E Prokipchuk
Journal:  Am J Dig Dis       Date:  1977-11
View more
  2 in total

1.  Immunohistochemical study of fibronectin, lysozyme, and alpha-fetoprotein (AFP) in human hepatocellular carcinoma.

Authors:  H Okushin; G Yamada; H Nagashima
Journal:  Gastroenterol Jpn       Date:  1987-02

2.  Deletion of the nuclear receptor RORα in macrophages does not modify the development of obesity, insulin resistance and NASH.

Authors:  Laurent L'homme; Benan Pelin Sermikli; Olivier Molendi-Coste; Sébastien Fleury; Sandrine Quemener; Mathilde Le Maître; Marie-Laure Joseph; Laurent Pineau; Christian Duhem; Barbara Gross; Emmanuelle Vallez; Anne Tailleux; Bart Staels; David Dombrowicz
Journal:  Sci Rep       Date:  2020-12-03       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.